Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
48°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
779.46
+42.26 (+5.73%)
Streaming Delayed Price
Updated: 3:03 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
76
77
Next >
S&P 500 Hits 5,000, Magnificent 7 Tops $13 Trillion, Commercial Real Estate Cracks Emerge: The Week In The Markets
February 09, 2024
The S&P 500 index surged past 5,000, led by tech giants. Tesla falls to ninth in market cap, Novo Nordisk disrupts food industry, Ackman targets retail investors.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of Eli Lilly Popped This Week
February 09, 2024
The pharmaceutical giant is gaining momentum, and investors are excited.
Via
The Motley Fool
3 Stocks to Sell Immediately Before the Bubble Bursts: February 2024
February 09, 2024
These three high-flying stocks to sell are set for a major decline when the stock market bubble pops. It's time to dump them.
Via
InvestorPlace
Is Tesla Still A Magnificent 7 Stock? EV Maker Could Get Bumped By These Companies
February 09, 2024
Tesla, relegated from seventh to ninth on the mega-cap leaderboard, can give way to other companies that are more 'magnificent.'
Via
Benzinga
Is Eli Lilly Stock a Buy Now?
February 09, 2024
Eli Lilly's valuation is approaching $700 billion.
Via
The Motley Fool
4 Reasons Why 2024 Could Be Eli Lilly's Worst Year for the Rest of This Decade
February 08, 2024
Lilly's headwinds in 2024 should only be temporary challenges.
Via
The Motley Fool
LLY Vs NVO: Which One Is Likely To Become A $1T Company First
February 08, 2024
Tackling growing waistlines is expected to yield much shareholder value.
Via
Talk Markets
Market Whales and Their Recent Bets on LLY Options
February 07, 2024
Via
Benzinga
SPDR ETF Report For Thursday, February 8
February 09, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Thursday, February 8
Via
Talk Markets
Topics
ETFs
Jim Cramer Says Investors Should Look Beyond Apple, Meta And Other Magnificent 7 Stocks: 'You Might Be Missing Out On Some Huge Gains'
February 08, 2024
Jim Cramer, the host of CNBC's "Mad Money," has suggested that investors should look beyond the Magnificent Seven tech stocks for potential high-yield investments.
Via
Benzinga
Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review
February 08, 2024
The S&P 500 hit 5,000. Arm, Palantir and Cloudflare rose sharply.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
February 08, 2024
Investors are still excited about obesity treatments and weight-management drugs.
Via
The Motley Fool
S&P 500 Hits 5,000 Milestone, Yet Concerns Of Overvaluation Versus Its Equal-Weight Counterpart Mount
February 08, 2024
S&P 500 index at 5,000 points; caution signals emerge in comparison to equal-weight index. Magnificent Seven heavyweights contribute 64% of returns.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
February 08, 2024
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.
Via
InvestorPlace
Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher
February 08, 2024
Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.
Via
Benzinga
Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug
February 08, 2024
The company is looking to take on Eli Lilly's tirzepatide as both a shot and a pill for weight loss.
Via
Investor's Business Daily
What's Going On Eli Lilly Stock Thursday?
February 08, 2024
Eli Lilly's impressive stock surge, better-than-expected Q4 results, and positive analyst reviews.
Via
Benzinga
The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry
February 08, 2024
Novo Nordisk's groundbreaking weight-loss treatments are causing concern in the food industry. CEOs are seeking advice from the company.
Via
Benzinga
SPDR ETF Report For Wednesday, February 7
February 08, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Wednesday, February 7
Via
Talk Markets
Topics
ETFs
Apple, Chipotle And Eli Lilly Stocks Baffle Jim Cramer With Unusual Moves: 'Authentic Stupidity Is A Perfectly Plausible Explanation'
February 07, 2024
Cramer questioned the rationale behind the market's behavior, emphasizing that not all stock movements are logical, especially during earnings season.
Via
Benzinga
Triple Threat Of Key Reversals: Warning Shots Fired In 3 High Fliers
February 07, 2024
In a potential warning sign to investors, three high-flying stocks had key reversals on Tuesday. This means the stocks opened to new highs before trading below their previous closing price.
Via
Benzinga
Analysts Boost Eli Lilly's Forecast With High Hopes On Mounjaro, Zepbound Performance
February 07, 2024
Eli Lilly's SYNERGY-NASH Phase 2 study results and positive market outlook drive BMO's raised price target to $865. Morgan Stanley remains bullish on Mounjaro/Zepbound launch. BofA Securities cites...
Via
Benzinga
Abbott Laboratories Stock Getting Closer To Key Technical Benchmark
February 07, 2024
Abbott Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
SPDR ETF Report For Tuesday, February 6
February 07, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day just ended, Tuesday, February 6
Via
Talk Markets
Topics
ETFs
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript
February 06, 2024
LLY earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
February 06, 2024
Some of the best stocks to buy in February according to MarketMaster AI suggest that a major economic recovery is underway.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks
February 06, 2024
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.
Via
InvestorPlace
Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
February 06, 2024
At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Eli Lilly Stock Jumped as Much as 5.1% Today Then Gave Up Its Gains
February 06, 2024
Investors shouldn't worry that Lilly's gains quickly evaporated.
Via
The Motley Fool
Stocks In China Flying, Lifting Sentiment In Stock Markets Across The Globe, AI And Weight Loss Drugs Get Hotter
February 06, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
76
77
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.